Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lyme disease
Biotech
Pfizer, Valneva show Lyme disease shot effective for 2nd booster
The immune responses of VLA15 when assessed a month after the second booster “were similar to those reported after receiving the first booster dose.”
James Waldron
Sep 3, 2024 4:30am
Pfizer, Valneva overcome CRO Lyme disease recruitment problems
Dec 5, 2023 3:20pm
Pfizer links Lyme booster to phase 2 pediatric antibody response
Sep 7, 2023 7:30am
Pfizer cuts enrollment for Lyme disease trial after CRO debacle
Aug 22, 2023 1:00pm
Pfizer pulls 50% of people from phase 3 trial for GCP violations
Feb 17, 2023 6:00am
Pfizer-Valneva's Lyme vaccine triggers 6-month antibody response
Dec 1, 2022 8:00am
